Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Diabetes Reviews | journal | 1.396 Q1 | 68 | 67 | 126 | 5933 | 422 | 117 | 2.96 | 88.55 | 44.50 | |
2 | Current Neuropharmacology | journal | 1.385 Q1 | 103 | 120 | 169 | 12931 | 723 | 150 | 3.15 | 107.76 | 46.08 | |
3 | Current Gene Therapy | journal | 1.323 Q2 | 80 | 43 | 143 | 3620 | 462 | 134 | 3.06 | 84.19 | 45.25 | |
4 | Current Cancer Drug Targets | journal | 1.271 | 103 | 84 | 221 | 7769 | 816 | 205 | 2.78 | 92.49 | 36.24 | |
5 | Current Genomics | journal | 1.227 Q2 | 77 | 53 | 155 | 4773 | 392 | 136 | 1.81 | 90.06 | 36.72 | |
6 | Current Alzheimer Research | journal | 1.207 Q2 | 103 | 161 | 329 | 13050 | 1104 | 313 | 3.12 | 81.06 | 43.92 | |
7 | Current Cardiology Reviews | journal | 1.071 Q1 | 58 | 40 | 134 | 2921 | 316 | 121 | 1.60 | 73.03 | 27.88 | |
8 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.041 Q1 | 52 | 34 | 73 | 3074 | 256 | 69 | 3.29 | 90.41 | 32.88 | |
9 | CNS and Neurological Disorders - Drug Targets | journal | 1.003 Q1 | 96 | 144 | 500 | 12082 | 1247 | 440 | 2.47 | 83.90 | 44.31 | |
10 | Open AIDS Journal | journal | 0.895 Q2 | 22 | 21 | 34 | 900 | 58 | 32 | 1.19 | 42.86 | 45.30 | |
11 | Current Protein and Peptide Science | journal | 0.894 Q1 | 96 | 89 | 231 | 7561 | 533 | 203 | 2.33 | 84.96 | 40.44 | |
12 | Current Vascular Pharmacology | journal | 0.890 Q2 | 69 | 87 | 299 | 5574 | 629 | 252 | 2.15 | 64.07 | 38.16 | |
13 | Current Topics in Medicinal Chemistry | journal | 0.879 Q2 | 133 | 294 | 694 | 31134 | 1958 | 611 | 2.62 | 105.90 | 37.04 | |
14 | Clinical Practice and Epidemiology in Mental Health | journal | 0.834 Q2 | 58 | 20 | 78 | 887 | 171 | 77 | 1.84 | 44.35 | 40.00 | |
15 | Current Neurovascular Research | journal | 0.820 | 60 | 45 | 136 | 1964 | 321 | 123 | 2.35 | 43.64 | 38.57 | |
16 | Current Drug Abuse Reviews | journal | 0.752 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
17 | Current Clinical Pharmacology | journal | 0.733 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
18 | Mini-Reviews in Medicinal Chemistry | journal | 0.728 Q2 | 107 | 186 | 377 | 17338 | 1120 | 354 | 2.46 | 93.22 | 43.85 | |
19 | Current Stem Cell Research and Therapy | journal | 0.723 Q2 | 63 | 91 | 186 | 7987 | 422 | 168 | 2.12 | 87.77 | 42.17 | |
20 | MicroRNA (Shariqah, United Arab Emirates) | journal | 0.720 Q1 | 29 | 25 | 67 | 58 | 121 | 65 | 1.69 | 2.32 | 42.06 | |
21 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.648 Q3 | 63 | 39 | 130 | 2067 | 264 | 119 | 2.21 | 53.00 | 45.00 | |
22 | Current Hypertension Reviews | journal | 0.619 Q2 | 27 | 34 | 93 | 1858 | 134 | 83 | 1.38 | 54.65 | 42.11 | |
23 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.616 Q2 | 45 | 10 | 87 | 374 | 151 | 79 | 1.33 | 37.40 | 16.00 | |
24 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.587 Q2 | 28 | 20 | 61 | 1492 | 119 | 59 | 1.76 | 74.60 | 41.51 | |
25 | Infectious Disorders - Drug Targets | journal | 0.554 Q2 | 61 | 27 | 99 | 1165 | 146 | 89 | 1.41 | 43.15 | 48.35 | |
26 | Recent Patents on CNS Drug Discovery | journal | 0.513 Q2 | 36 | 18 | 45 | 786 | 76 | 38 | 1.48 | 43.67 | 52.83 | |
27 | Open Respiratory Medicine Journal | journal | 0.495 Q3 | 25 | 13 | 49 | 373 | 92 | 46 | 2.03 | 28.69 | 25.40 | |
28 | Current Aging Science | journal | 0.494 Q2 | 42 | 35 | 97 | 2866 | 154 | 91 | 1.49 | 81.89 | 42.86 | |
29 | Reviews on Recent Clinical Trials | journal | 0.484 Q2 | 35 | 42 | 111 | 2198 | 148 | 97 | 1.46 | 52.33 | 42.95 | |
30 | Current Drug Safety | journal | 0.462 Q3 | 41 | 52 | 121 | 2077 | 174 | 113 | 1.13 | 39.94 | 42.71 | |
31 | Current Radiopharmaceuticals | journal | 0.453 Q3 | 32 | 32 | 68 | 1103 | 91 | 64 | 0.95 | 34.47 | 36.57 | |
32 | Drug Metabolism Letters | journal | 0.383 Q3 | 31 | 37 | 61 | 1197 | 66 | 55 | 0.94 | 32.35 | 34.85 | |
33 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.359 Q3 | 43 | 26 | 90 | 1309 | 80 | 76 | 0.70 | 50.35 | 45.87 | |
34 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.353 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
35 | Current Psychiatry Reviews | journal | 0.345 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
36 | Current Rheumatology Reviews | journal | 0.332 Q3 | 29 | 33 | 80 | 2660 | 88 | 73 | 1.81 | 80.61 | 39.45 | |
37 | Recent Patents on Drug Delivery and Formulation | journal | 0.327 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
38 | Open Cardiovascular Medicine Journal | journal | 0.319 Q3 | 32 | 33 | 64 | 1014 | 54 | 64 | 0.83 | 30.73 | 25.50 | |
39 | Current Medical Imaging | journal | 0.304 Q3 | 37 | 48 | 101 | 2222 | 58 | 95 | 0.40 | 46.29 | 37.97 | |
40 | Combinatorial Chemistry and High Throughput Screening | journal | 0.301 Q3 | 70 | 97 | 281 | 3741 | 275 | 253 | 0.91 | 38.57 | 39.44 | |
41 | Current Nutrition and Food Science | journal | 0.279 Q3 | 32 | 45 | 125 | 1924 | 87 | 114 | 0.42 | 42.76 | 50.31 | |
42 | Current Pediatric Reviews | journal | 0.279 Q3 | 33 | 26 | 127 | 1290 | 89 | 113 | 1.00 | 49.62 | 43.14 | |
43 | Current Computer-Aided Drug Design | journal | 0.277 Q3 | 32 | 34 | 134 | 1503 | 145 | 119 | 0.79 | 44.21 | 32.18 | |
44 | Current Nanoscience | journal | 0.272 Q3 | 52 | 105 | 368 | 4903 | 408 | 353 | 1.06 | 46.70 | 36.80 | |
45 | Current Immunology Reviews | journal | 0.271 Q4 | 23 | 19 | 58 | 1629 | 36 | 51 | 0.32 | 85.74 | 42.86 | |
46 | Current Respiratory Medicine Reviews | journal | 0.270 Q3 | 15 | 40 | 142 | 2596 | 60 | 116 | 0.18 | 64.90 | 25.00 | |
47 | Recent patents on food, nutrition & agriculture | journal | 0.270 Q3 | 33 | 26 | 59 | 1266 | 64 | 54 | 0.81 | 48.69 | 56.10 | |
48 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.267 Q3 | 27 | 25 | 76 | 1341 | 74 | 67 | 0.96 | 53.64 | 39.56 | |
49 | Current Chemical Biology | journal | 0.267 Q3 | 26 | 17 | 54 | 619 | 63 | 50 | 0.61 | 36.41 | 40.48 | |
50 | Current Signal Transduction Therapy | journal | 0.232 Q3 | 22 | 23 | 78 | 575 | 37 | 72 | 0.09 | 25.00 | 32.20 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®